申请人:Ueno Yoshihide
公开号:US20060063762A1
公开(公告)日:2006-03-23
The compound of the formula (I):
wherein W is a group of the following formula (VIII) binding to any possible position on the Q:
Q is, together with W, a group of the formula: —C(W)═C(R
3A
)—N(R
3
)—, etc.; R
3A
is H or optionally substituted lower alkyl; R
4
, R
5
, R
6
, and R
7
are independently H or optionally substituted lower alkyl; R
1
is optionally substituted lower alkyl, etc.; R
2
is H, etc.; R
3
is H, etc.; Ar is phenyl, etc., or a pharmaceutically acceptable salt thereof, where these compounds exhibiting β3-adrenoceptor-stimulating activity and being useful as a medicament for treatment of obesity, etc.
化合物的化学式(I):其中W是以下化学式(VIII)的基团,可结合到Q的任何可能位置:Q与W一起是以下化学式的基团:—C(W)═C(R3A)—N(R3)—等;R3A为H或可选择性取代的低碳基;R4、R5、R6和R7独立地为H或可选择性取代的低碳基;R1为可选择性取代的低碳基等;R2为H等;R3为H等;Ar为苯基等,或其药学上可接受的盐,这些化合物表现出β3肾上腺素能受体刺激活性,可用作治疗肥胖症等疾病的药物。